PepTalk 2017
PepTalk 2017

Pipeline Six Header

Cambridge Healthtech Institute’s Ninth Annual
Protein Purification and Recovery
Streamlining Processes with Innovative Technologies
January 10-11, 2017 | Hilton San Diego Bayfront | San Diego, CA

 

Protein purification is the most costly and time-consuming process in the manufacture of proteins. Challenges are multiplied when purifying complex molecules, such as membrane proteins, bispecifics and antibody-drug conjugates. This leading Protein Purification and Recovery meeting explores how experts are optimizing processes to achieve pure protein while curtailing cost and time. Along with innovating “traditional” technologies such as Protein A and chromatography, leaders also address alternatives and breakthroughs, such as continuous processing.

Preliminary Agenda


PURIFICATION STRATEGIES FOR CONQUERING DISEASE


KEYNOTE PRESENTATION: Advances in Purification Technologies Accelerate Vaccine Development

Yan-ping Yang, Ph.D., Senior Director and Head, Bioprocess R&D North America, Sanofi Pasteur


Using Interaction Proteomics to Identify Novel Signaling Components Relevant for Cancer

Alexey Veraksa, Ph.D., Associate Professor, Biology, University of Massachusetts, Boston


PURIFYING COMPLEX MOLECULES

New Chemical Tools for Stabilization of Membrane Proteins

Qinghai Zhang, Ph.D., Associate Professor, Integral Structural and Computational Biology, The Scripps Research Institute

Modular Approaches for Complex Therapeutic Molecules: Reinventing Smart Bioprocessing

Stefan R. Schmidt, Ph.D., MBA, Vice President, Rentschler Biotechnology


BEAD-BASED PURIFICATION

Magnetic Beads for Antibody Purification

Ray Low, Ph.D., Scientist, Biologics Optimization, Amgen

Core Bead Chromatography for Preparation of Highly Pure, Infectious Respiratory Syncytial Virus in the Negative Purification Mode

Sophia T. Mundle, Ph.D., Deputy Director, Protein Chemistry, Sanofi Pasteur


INNOVATING PURIFICATION PROCESSES

Overload vs. Bind and Elute Cation Exchange Chromatography: A Case Study

David Glover, Engineer II, Purification Development, Genentech

The RAS Initiative at the Frederick National Lab: Producing RAS and Ras-Binding Proteins for Structural Biology, Biochemistry, and Assay Development

William Gillette, Ph.D., Principal Scientist, RAS Protein Production, and Deputy Director, Protein Expression Laboratory, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc.

Bespoke Bacterial Expression Vectors and Automated 3-Dimensional Lab Scale Purification Increases Throughput and Capacity in a Drug Discovery Protein Production Facility

Christopher Gray, Ph.D., Structural Biology Team Leader, Drug Discovery Program, CRUK Beatson Institute




For questions about the meeting, please contact:

Mary Ruberry
Senior Conference Director
Cambridge Healthtech Institute
Phone: 781-972-5421
Email: mruberry@healthtech.com

For partnering & sponsorship information, please contact:

Companies A-K
Jason Gerardi
Manager, Business Development
Cambridge Healthtech Institute
Phone: 781-972-5452
Fax: 781-972-5470
Email: jgerardi@healthtech.com

Companies L-Z
Carol Dinerstein
Director, Business Development
Cambridge Healthtech Institute
Phone: 781-972-5471
Fax: 781-972-5470
Email: dinerstein@healthtech.com